SouthState Corp’s Core Laboratories CLB Stock Holding History

SouthState Corp’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7	Closed	-$105	–	1632
2025 Q1	$105	Buy	+7	New	+$117	﹤0.01%	1681

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

SouthState Corp's CLB Position: Q2 2025 in Review

SouthState Corp sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 7 shares — an estimated $105 sold.

SouthState Corp first reported a position in CLB in Q1 2025 and held it in 1 quarter. The position peaked at $105 in Q1 2025. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.

SouthState Corp reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
SouthState Corp sold 7 Core Laboratories shares in Q2 2025, an estimated $105.
SouthState Corp first reported a position in Core Laboratories in Q1 2025 and held it in 1 quarter.
SouthState Corp's Core Laboratories position peaked at $105 in Q1 2025.
191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.

Based on SouthState Corp's 13F filing for Q2 2025, filed 6 Aug 2025.